Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancerSally J. Adua(Yale Cancer Center), Don X. Nguyen(Yale Cancer Center)Nature CommunicationsDecember 12, 202210.1038/s41467-022-34889-zCited by 46SaveCiteExport RISWatch citationsRelated PapersActivation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase|Cell|2011|276Transcriptomic Hallmarks of Tumor Plasticity and Stromal Interactions in Brain Metastasis|Cell Reports|2019|67